These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2642517)

  • 21. [Diagnosis and clinical aspects of Yersinia arthritis].
    Hermann B; Eggers-Ströder G
    Z Orthop Ihre Grenzgeb; 1993; 131(1):28-31. PubMed ID: 8480436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study.
    Dalby T; Rasmussen E; Schiellerup P; Krogfelt KA
    BMC Microbiol; 2017 May; 17(1):125. PubMed ID: 28545413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis.
    Granfors K; Ogasawara M; Hill JL; Lahesmaa-Rantala R; Toivanen A; Yu DT
    J Infect Dis; 1989 Jun; 159(6):1142-7. PubMed ID: 2656882
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum IgA to enterobacteria in ankylosing spondylitis.
    van Bohemen CG; Nabbe AJ; Goei The HS; Mazurkiewicz ES; van der Linden S; Zanen HC
    Scand J Rheumatol; 1986; 15(3):305-9. PubMed ID: 3541170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal immunoglobulin A (IgA) antibodies to Yersinia enterocolitica in mice orally vaccinated and infected.
    Shimono K; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):273-7. PubMed ID: 2739202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response in Yersinia pseudotuberculosis III infection: analysis of an outbreak.
    Ståhlberg TH; Tertti R; Wolf-Watz H; Granfors K; Toivanen A
    J Infect Dis; 1987 Aug; 156(2):388-91. PubMed ID: 3298459
    [No Abstract]   [Full Text] [Related]  

  • 27. [Contribution to the differential diagnosis of Yersinia enterocolitica infection and systemic inflammatory diseases of connective tissue based on an observed case].
    Wierzbowska M
    Pediatr Pol; 1988 Jul; 63(7):443-5. PubMed ID: 3247238
    [No Abstract]   [Full Text] [Related]  

  • 28. [Utilization of released proteins (RPs) of Yersinia enterocolitica for serologic diagnosis of yersiniosis. III. Western-blot].
    Rastawicki W; Jagielski M; Gierczyński R
    Med Dosw Mikrobiol; 2004; 56(4):335-42. PubMed ID: 15959989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA anti-Yersinia antibodies and the outcome of Yersinia-triggered reactive arthritis.
    Lehtinen K; Granfors K; Toivanen A; Isomaki H
    Clin Exp Rheumatol; 1988; 6(4):424-5. PubMed ID: 3229034
    [No Abstract]   [Full Text] [Related]  

  • 30. Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis.
    Lahesmaa-Rantala R; Heesemann J; Lehtonen OP; Granfors K; Toivanen A
    Ann Rheum Dis; 1989 Dec; 48(12):1003-6. PubMed ID: 2619352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.
    Granfors K; Jalkanen S; von Essen R; Lahesmaa-Rantala R; Isomäki O; Pekkola-Heino K; Merilahti-Palo R; Saario R; Isomäki H; Toivanen A
    N Engl J Med; 1989 Jan; 320(4):216-21. PubMed ID: 2643047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The results of the dynamic observation of patients with reactive Yersinia arthritis].
    Ivanova MM; Akimova TF; Inina LI; Iushchenko GV; Izomiaki Kh; Lechtinen K; Granfors K
    Ter Arkh; 1991; 63(5):18-20. PubMed ID: 1887403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ELISA & tube agglutination for the detection of anti Yersinia enterocolitica antibodies among arthritis patients.
    Radha M; Sanjeevi CB; Narayanan PR; Chandrasekaran AN
    Indian J Pathol Microbiol; 1986 Jan; 29(1):9-14. PubMed ID: 3781617
    [No Abstract]   [Full Text] [Related]  

  • 34. Human antibody response to individual chromosome- and plasmid-encoded antigens of Yersinia enterocolitica 0:3.
    Ståhlberg TH; Granfors K; Toivanen A
    Contrib Microbiol Immunol; 1987; 9():290-5. PubMed ID: 3665508
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental animal models of Yersinia infection and Yersinia-induced arthritis.
    Hill JL; Yong Z; Laheji K; Kono DH; Yu DT
    Contrib Microbiol Immunol; 1987; 9():228-32. PubMed ID: 3665502
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological and bacteriological aspects of reactive arthritis.
    Toivanen A; Granfors K; Lahesmaa-Rantala R; Toivanen P
    Rheumatol Int; 1989; 9(3-5):201-3. PubMed ID: 2692127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis in Yersinia enterocolitica infection.
    Stolk-Engelaar V; Hoogkamp-Korstanje J
    Contrib Microbiol Immunol; 1995; 13():137-9. PubMed ID: 8833817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-immunological parallels in yersiniosis].
    Iushchenko GV; Novoselova EIu
    Sov Med; 1987; (8):94-7. PubMed ID: 3423976
    [No Abstract]   [Full Text] [Related]  

  • 39. [Yersinia enterocolitica infections].
    Ejlertsen T
    Ugeskr Laeger; 1987 Dec; 149(50):3387-90. PubMed ID: 3433538
    [No Abstract]   [Full Text] [Related]  

  • 40. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis.
    Appel H; Mertz A; Distler A; Sieper J; Braun J
    J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.